SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-126416
Filing Date
2024-11-13
Accepted
2024-11-13 16:38:53
Documents
97
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tsha-20240930.htm   iXBRL 10-Q 2124299
2 EX-31.1 tsha-ex31_1.htm EX-31.1 16560
3 EX-31.2 tsha-ex31_2.htm EX-31.2 16596
4 EX-32.1 tsha-ex32_1.htm EX-32.1 9293
5 EX-32.2 tsha-ex32_2.htm EX-32.2 9329
6 GRAPHIC img39574939_0.jpg GRAPHIC 49073
7 GRAPHIC img39574939_1.jpg GRAPHIC 116861
8 GRAPHIC img39574939_2.jpg GRAPHIC 70437
9 GRAPHIC img39574939_3.jpg GRAPHIC 99208
10 GRAPHIC img39574939_4.jpg GRAPHIC 82564
11 GRAPHIC img39574939_5.jpg GRAPHIC 84422
12 GRAPHIC img39574939_6.jpg GRAPHIC 88441
13 GRAPHIC img39574939_7.jpg GRAPHIC 69435
14 GRAPHIC img39574939_8.jpg GRAPHIC 35460
15 GRAPHIC img39574939_9.jpg GRAPHIC 90564
16 GRAPHIC img39574939_10.jpg GRAPHIC 88398
17 GRAPHIC img39574939_11.jpg GRAPHIC 51097
18 GRAPHIC img39574939_12.jpg GRAPHIC 79759
19 GRAPHIC img39574939_13.jpg GRAPHIC 81752
  Complete submission text file 0000950170-24-126416.txt   12512025

Data Files

Seq Description Document Type Size
20 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tsha-20240930.xsd EX-101.SCH 1666793
100 EXTRACTED XBRL INSTANCE DOCUMENT tsha-20240930_htm.xml XML 1735331
Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Filer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39536 | Film No.: 241455064
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)